ADAP

Adaptimmune Therapeutics
ADAP

Overview Fund Activity

41 hedge funds and large institutions have $181M invested in Adaptimmune Therapeutics in 2015 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 13 reducing their positions, and 10 closing their positions.

Holders
41
Holders Change
-4
Holders Change %
-8.89%
% of All Funds
1.15%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
6
Increased
9
Reduced
13
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Capital World Investors
1
Capital World Investors
California
$20.5M
2
Citadel Advisors
2
Citadel Advisors
Florida
$7.84M
3
TCM
3
Tekla Capital Management
Massachusetts
$3.38M
4
Jennison Associates
4
Jennison Associates
New York
$5.81M
5
IHM
5
Iguana Healthcare Management
New York
$898K

Top Sellers

1
O
1
OrbiMed
New York
$2.11M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$57.7M
3
ACPU
3
Arrowgrass Capital Partners (US)
Delaware
$0
4
FCM
4
Farallon Capital Management
California
$0
5
NHAS
5
Novo Holdings A/S
Denmark
$16.9M
Name Market Value Shares Shares
Change 		Shares
Change %
Bank of America
51
Bank of America
North Carolina
– – -200 Closed
1 2
3